Picture of Morgan Stanley logo

MS Morgan Stanley News Story

0.000.00%
us flag iconLast trade - 00:00
FinancialsBalancedLarge CapNeutral

REG - Morgan Stanley Cap - Rule 38.5 - ABBVIE INC.




 



RNS Number : 1927E
Morgan Stanley Capital Services LLC
26 February 2020
 

 

 FORM 38.5

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER  RULES, 2007 (AS AMENDED)

 

DEALINGS BY CONNECTED EXEMPT MARKET-MAKERS

 

1.             KEY INFORMATION

 Name of exempt market-maker

   Morgan Stanley Capital Services LLC

 Company dealt in

   ABBVIE INC.

 Class of relevant security to which the dealings being disclosed relate (Note 1)

  US$0.01 COMMON STOCK

 Date of dealing

   25 FEBRUARY 2020

 

 

2.             DEALINGS (Note 2)

 

(a)           Purchases and sales

 Total number of relevant secuities accquired

 Highest price paid (Note 3)

 Lowest price paid (Note 3)

  350,763

 93.2800 USD

 88.1300 USD

 

 Total number of relevant secuities disposed

 Highest price paid (Note 3)

 Lowest price paid (Note 3)

  44,294

 93.3300 USD

 88.2800 USD

 

 

(b)           Derivatives transactions (other than options transactions)

 

 Product name, e.g. CFD

 Nature of transaction

                (Note 4)

 Number of relevant securities

                (Note 5)

 Price per unit

 CFD

 LONG

 4,000

 88.2909 USD

 CFD

 LONG

 1,000

 89.1800 USD

 CFD

 LONG

 8

 89.1800 USD

 CFD

 LONG

 340

 89.3308 USD

 CFD

 LONG

 6,300

 89.4273 USD

 CFD

 LONG

 300

 89.4273 USD

 CFD

 LONG

 1,000

 89.4273 USD

 CFD

 LONG

 800

 89.4273 USD

 CFD

 LONG

 600

 89.4273 USD

 CFD

 LONG

 3,500

 89.4273 USD

 CFD

 LONG

 3,200

 89.4273 USD

 CFD

 LONG

 1,000

 89.4273 USD

 CFD

 LONG

 98

 91.0699 USD

 CFD

 LONG

 4,232

 91.0699 USD

 CFD

 LONG

 20

 91.2300 USD

 CFD

 LONG

 8,660

 92.3610 USD

 CFD

 LONG

 2,598

 92.4413 USD

 CFD

 LONG

 1,500

 92.9626 USD

 CFD

 SHORT

 1,330

 88.8856 USD

 CFD

 SHORT

 32,794

 88.8856 USD

 CFD

 SHORT

 2,600

 89.0130 USD

 CFD

 SHORT

 3,006

 89.1653 USD

 CFD

 SHORT

 885

 89.1653 USD

 CFD

 SHORT

 6,543

 89.1653 USD

 CFD

 SHORT

 1,134

 89.1653 USD

 CFD

 SHORT

 200

 89.1800 USD

 CFD

 SHORT

 29

 89.1800 USD

 CFD

 SHORT

 2

 89.1800 USD

 CFD

 SHORT

 20

 89.3400 USD

 CFD

 SHORT

 3,900

 89.4880 USD

 CFD

 SHORT

 100

 89.7000 USD

 CFD

 SHORT

 768

 90.5500 USD

 CFD

 SHORT

 877

 90.5500 USD

 CFD

 SHORT

 315

 90.8931 USD

 CFD

 SHORT

 7,773

 90.8931 USD

 CFD

 SHORT

 6,841

 91.0224 USD

 CFD

 SHORT

 275,088

 93.1400 USD

 

 

(c)            Options transactions in respect of existing relevant securities

 

i)           Writing, selling, purchasing or varying

 

 Product name, eg call option

 Writing, selling, purchasing, varying etc

 Number of securities to which the option relates (Note 5)

 Exercise Price

 Type, e.g American, European etc

 Expiry Date

 Option money paid/received per unit (Note 3)

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 

(ii) Exercising

 

 Product name, eg call option

 Number of securities

 Exercise price per unit (Note 3)

 N/A

 N/A

 N/A 

 

 

3. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 Date of disclosure

 26 FEBRUARY 2020

 Contact Name

Craig Horsley

 Telephone Number

+44(141) 245 7736

 Name of offeree/offeror with which connected

ABBVIE INC.

Nature of connection (Note 6)

Advisory

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ISEUNARRRSUUUAR

Recent news on Morgan Stanley

See all news